Controversy Kicks Up Over a Drug Meant to Prevent Premature Birth

November 5, 2019

(NPR) – An independent panel of advisers to the Food and Drug Administration recommended last week that a medication to prevent preterm birth be taken off the market because, the advisers decided, the preponderance of evidence suggests it doesn’t work. But some other leading OB-GYNs say they hope the FDA won’t take the panel’s advice this time. The medication, brand-named Makena, is a progestin, a synthetic form of the hormone progesterone.

Recommended Reading